Spencer Trask & Co.

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Spencer Trask & Co.
Industry Financial services
Headquarters Greenwich, CT, United States
Key people
Kevin Kimberlin
(Chairman)
William Clifford
(CEO)
Services Build advanced technology companies
Website spencertraskco.com

Spencer Trask & Co. is a privately held advanced technology development company. The firm works with entrepreneurs, CEOs, corporate partners, venture firms and high net worth individuals to start and grow high impact ventures.

Members and affiliates of Spencer Trask & Co. are founders of, advisors to, and investors in private and public companies through direct investments, a brokerage affiliate and numerous limited liability companies.

Spencer Trask & Co., has been instrumental in the formative stage of companies that pioneered many technological and scientific advancements, including: genomics with Myriad Genetics,[1] healthcare reform with Health Dialog,[2] patent development with Intellectual Ventures,[3][4] the Internet with Ciena,[5] cloud computing infrastructure with Aperture,[6] and open innovation with Innocentive[7][8] and inno360 (in partnership with P&G, and the Air Force Research Labs.[9])

Several Spencer Trask-backed firms have been acquired recently, including OpenTable ($2.6 billion), Prolor (stock swap worth $1.2 billion), El Super (2013 revenues topped $1.1 billion) and Prospect Medical ($363 million).

The firm is the legacy of Mr. Spencer A. Trask who financed Thomas Edison and was founding trustee of the predecessor to General Electric, the president of the first electricity firm, Consolidated Edison, and chairman of the New York Times.

References

Further reading